Real-time Monitoring of Glucose with MicroEye® & ContinuMon®
Research type
Research Study
Full title
A single-centre, open study to investigate the performance of the intravenous MicroEye® blood sampling device in combination with the ContinuMon® glucose and lactate measurement system in ICU patients
IRAS ID
224549
Contact name
Jonathan Cooper
Contact email
Sponsor organisation
Probe Scientific Ltd.
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
This study is a mono-centric, open-label study aiming to assess accuracy and reliability of the combination of the MicroEye® sampling device and the ContinuMon® measurement device for glucose measurement by comparison with reference values as measured by blood gas analyser or Lab based analysis for withdrawn blood samples from ICU patient.
During the study intravenous microdialysis will be performed using the MicroEye® device and the dialysate samples will be measured using the ContinuMon® device. Glucose measurements in dialysate will be compared to glucose blood results obtaining using an agreed reference method such as a blood gas analyser. Blood sampling will be conducted as required for the routine care of the patients’ with additional sampling up to 10 times daily when appropriate. The addition of an anticoagulant to the MicroEye® perfusate will only be considered if the patient is not receiving suitable anti-coagulation therapy.
REC name
East of England - Essex Research Ethics Committee
REC reference
17/EE/0398
Date of REC Opinion
17 Nov 2017
REC opinion
Further Information Favourable Opinion